Meyka Pro banner
908 Devices Inc.

908 Devices Inc. (MASS) Stock Overview

Explore 908 Devices Inc.’s financial performance, market position, analyst ratings, and future outlook.

MASS●NASDAQ
HealthcareMedical - Specialties
$12.34
$0.49(4.14%)
U.S. Market opens in 15h 8m

908 Devices Inc. (MASS)

Meyka AI Score

Z

Key Financials

Market Cap506.3M
P/E Ratio-13.35
EPS (TTM)$-0.60
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$11.70
3 Months$8.27
1 Year Target$8.36

MASS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of 908 Devices Inc. (NASDAQ: MASS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, 908 Devices Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MASS on the NASDAQ shows an RSI of 71.83, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $8.36 for the NASDAQ listing.

Key metrics behind 908 Devices Inc.'s NASDAQ-traded stock include a P/E ratio of -13.35 and a market capitalization of 506.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MASS on the NASDAQ.

Price Performance (NASDAQ: MASS)

1-Day Change
4.14%
5-Day Change
7.12%
1-Month Change
15.005%
3-Month Change
41.84%
6-Month Change
114.61%
Year-to-Date (YTD) Change
135.05%
1-Year Change
40.87%
3-Year Change
93.72%
5-Year Change
-62.05%
All-Time (Max) Change
-74.82%

Contact Information

857 254 1500
44 3rd Avenue, Burlington, MA, 01803

Company Facts

1,720 Employees
IPO DateDec 18, 2020
CountryUS
Actively Trading

Frequently Asked Questions